German antitrust authorities have blocked Asklepios’s previously-cleared acquisition of more than 10 percent in rival hospital cooperation Rhoen-Klinikum after finding Asklepios failed to meet concessions originally agreed upon for the deal. Reports say Germany’s Federal Cartel Office agreed in March to allow the buyout that would see 10.1 percent of Rhoen in control of Asklepios as long as Asklepios sold a hospital and medical center in one region. Since, the cooperative has reportedly not met those conditions; Rhoen told media that the watchdog has now blocked the buyout.
Featured News
DOJ Clears Paramount’s $110 Billion Warner Bros. Discovery Acquisition
Jun 12, 2026 by
CPI
States Move Ahead with AI Safeguards for Minors as Federal Action Remains Uncertain
Jun 12, 2026 by
CPI
Dana, Eaton Strike Auto Parts Deal Worth More Than $10 Billion
Jun 11, 2026 by
CPI
CFTC Proposes New Rules For What’s Allowed on Prediction Markets
Jun 11, 2026 by
CPI
Connecticut vs. California’s Data Broker Laws: New Compliance Challenges
Jun 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – (Geo)Political Antitrust
May 28, 2026 by
CPI
Competition Policy in Turbulent Geopolitical Times
May 28, 2026 by
Christophe Carugati & Annabelle Gawer
The New Political Determinants of U.S. Antitrust Policy
May 28, 2026 by
Aziz Z. Huq
The Geopolitical Rewiring of Antitrust
May 28, 2026 by
Hayane C. Dahmen
Three Strikes Against Political Antitrust
May 28, 2026 by
Nolan McCarty & Sepehr Shahshahani